SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Metropolitan Life Insurance Co/NY – ‘SC 13G/A’ on 2/11/03 re: Nexell Therapeutics Inc

On:  Tuesday, 2/11/03, at 4:44pm ET   ·   Accession #:  728618-3-8   ·   File #:  5-41947

Previous ‘SC 13G’:  ‘SC 13G/A’ on 2/11/03   ·   Next:  ‘SC 13G/A’ on 2/12/03   ·   Latest:  ‘SC 13G/A’ on 2/14/06

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer

 2/11/03  Metropolitan Life Insurance Co/NY SC 13G/A               1:10K  Nexell Therapeutics Inc

Amendment to Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G/A    Nexell Therapeutics 13G/A Filing                       6±    24K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Item 4. Ownership:
"Item 5. Ownership of Five Percent or Less of a Class:
"Item 6. Ownership of More than Five Percent on Behalf of Another Person: (NOT APPLICABLE.)
"Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
"Item 8. Identification and Classification of Members of the Group: (NOT APPLICABLE.)
"Item 9. Notice of Dissolution of Group: (NOT APPLICABLE.)


UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Nexell Therapeutics, Inc. ________________________________________ (Name of Issuer) Common Stock ________________________________________ (Title of Class of Securities) 65332H203 _________________________ (CUSIP Number) October 23, 2002 ________________________________________ (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of the cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). MetLife, Inc. (I.R.S. NO. 13-4075851) 2. Check the Appropriate Box if a Member of a Group (a) [ ] Not applicable (b) [ ] Not applicable 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION A Delaware corporation 5. SOLE VOTING POWER -0- NUMBER OF SHARES 6. SHARED VOTING POWER BENEFICIALLY -0- OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH -0- 8. SHARED DISPOSITIVE POWER -0- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.0% 12. TYPE OF REPORTING PERSON HC 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Metropolitan Life Insurance Company (I.R.S. NO. 13-5581829) 2. Check the Appropriate Box if a Member of a Group (a) [ ] Not applicable (b) [ ] Not applicable 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION A New York stock life insurance company 5. SOLE VOTING POWER -0- NUMBER OF SHARES 6. SHARED VOTING POWER BENEFICIALLY -0- OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH -0- 8. SHARED DISPOSITIVE POWER -0- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.0% 12. TYPE OF REPORTING PERSON IC Item 1 (a). Name of Issuer Nexell Therapeutics, Inc. (b). Address of Issuer's Principal Executive Offices: 9 Parker Irvine, CA 92618 Item 2 (a). Name of Person(s) Filing MetLife, Inc. By: Gwenn L. Carr, Vice-President and Secretary Metropolitan Life Insurance Company By: Dorothy L. Murray, Assistant Vice-President (b). Address of Principal Business Office MetLife, Inc. One Madison Avenue New York, New York 10010-3690 Metropolitan Life Insurance Company One Madison Avenue New York, New York 10010-3690 (c). Citizenship MetLife, Inc. A Delaware corporation Metropolitan Life Insurance Company A New York stock life insurance company (d). Title of Class of Securities Common Stock (e). CUSIP Number 65332H203 Item 3. If this statement is filed pursuant to sections 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C.78o); (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [X] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);* (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) [ ] An investment adviser in accordance with section 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in Accordance with section 240.13d-1(b)(1)(ii)(F); (g) [X] A parent holding company or control person in accordance with section 240.13d-1(b)(1)(ii)(G);* (h) [ ] A savings association as defined in section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (I) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); or (j) [ ] Group, in accordance with section 240.13d-1(b)(1) (ii)(J). * See Item 7 Item 4. Ownership: Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: -0- (b) Percent of Class: 0.0% (c) Number of shares as to which such person has (i) sole power to vote or to direct the vote: -0- (ii) shared power to vote or to direct the vote: -0- (iii)sole power to dispose or to direct the disposition of: -0- (iv) shared power to dispose or to direct the disposition of: -0- Item 5. Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More than Five Percent on Behalf of Another Person: (NOT APPLICABLE.) Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: See Exhibit A Item 8. Identification and Classification of Members of the Group: (NOT APPLICABLE.) Item 9. Notice of Dissolution of Group: (NOT APPLICABLE.) Item 10. Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and were held in the ordinary course of business and were not acquired and were not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and were not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 11, 2003 MetLife, Inc. By: /s/Gwenn L. Carr Title: Vice-President and Secretary Metropolitan Life Insurance Company By: /s/Dorothy L. Murray Title: Assistant Vice-President Exhibit Index Exhibit A: Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent's Holding Company Exhibit B: Joint Filing Agreement under Rule 13d-1(k)(1) Exhibit A: Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent's Holding Company MetLife, Inc. is a parent holding company that is filing this statement pursuant to Rule 13d-1(b)(1)(ii)(G). On April 7, 2000, Metropolitan Life Insurance Company ("MLIC"), the relevant subsidiary, became a wholly-owned subsidiary of MetLife, Inc. MLIC is an insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). Exhibit B: Joint Filing Agreement under Rule 13d-1(k)(1) In accordance with Rule 13d-1(k)(1) of Regulation 13D-G of the Securities Exchange Act of 1934, the persons or entities below agree to the joint filing on behalf of each of them of the Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock of Nexell Therapeutics, Inc., and agree that such statement is, and any amendments thereto filed by any of them will be, filed on behalf of each of them, and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof the undersigned hereby execute this Agreement this 11th day of February, 2003. MetLife, Inc. By: /s/Gwenn L. Carr Title: Vice-President and Secretary Metropolitan Life Insurance Company By: /s/Dorothy L. Murray Title: Assistant Vice- President SCHEDULE 13G CUSIP No. 65332H203 SCHEDULE 13G CUSIP No. 65332H203

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘SC 13G/A’ Filing    Date    Other Filings
Filed on:2/11/03SC 13G/A
10/23/024
4/7/00
 List all Filings 
Top
Filing Submission 0000728618-03-000008   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 7:31:31.1pm ET